Financials

v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash $ 4,685,000 $ 7,025,000
Restricted cash 75,000 75,000
Grant receivable 70,000
Tax credit receivable 691,000 706,000
Prepaid expenses and other current assets 418,000 328,000
Total current assets 5,939,000 8,134,000
Property and equipment, net 81,000 93,000
Deposits 95,000 95,000
Operating lease right-of-use assets, net (including $89 and $152 to related party) 1,311,000 1,390,000
Total assets 7,426,000 9,712,000
Current liabilities:    
Accounts payable and accrued expenses 1,886,000 1,876,000
Current maturities of operating lease liabilities (including $58 and $49 to related party) 343,000 334,000
Total current liabilities 2,229,000 2,210,000
Long-term liabilities:    
Operating lease liabilities (including $32 and $104 to related party) 1,081,000 1,171,000
Total long-term liabilities 1,081,000 1,171,000
Total liabilities 3,310,000 3,381,000
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.001 a par value: 100,000 shares authorized as of March 31, 2026 and December 31, 2025; 13,787 and 13,784 shares issued and outstanding as of March 31, 2026 and December 31, 2025 13,000 13,000
Additional paid-in capital 348,651,000 348,567,000
Accumulated deficit (344,548,000) (342,249,000)
Total stockholders’ equity 4,116,000 6,331,000
Total liabilities and stockholders’ equity $ 7,426,000 $ 9,712,000

Source

v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues and grant income:    
Grant income $ 225,000
Operating expenses:    
Research and development 1,371,000 1,360,000
General and administrative 1,210,000 981,000
Total operating expenses 2,581,000 2,341,000
Loss from operations (2,356,000) (2,341,000)
Other income:    
Interest income, net 22,000 37,000
Foreign exchange gain, net 35,000 3,000
Total other income, net 57,000 40,000
Net loss $ (2,299,000) $ (2,301,000)
Net loss per common share, basic $ (0.17) $ (0.23)
Net loss per common share, diluted $ (0.17) $ (0.23)
Weighted average number of common shares outstanding, basic 13,786 10,174
Weighted average number of common shares outstanding, diluted 13,786 10,174

Source

v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (2,299,000) $ (2,301,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 12,000 25,000
Stock-based compensation 84,000 82,000
Decrease right of use assets 79,000 74,000
Changes in operating assets and liabilities:    
Grant receivable (70,000)
Prepaid expenses and other current assets (90,000) 45,000
Tax credit receivable 15,000 (229,000)
Deposits (57,000)
Accounts payable and accrued expenses 10,000 (505,000)
Operating lease liabilities (81,000) (73,000)
Net cash used in operating activities (2,340,000) (2,939,000)
Net decrease in cash and restricted cash (2,340,000) (2,939,000)
Cash and restricted cash at beginning of period 7,100,000 9,935,000
Cash and restricted cash at end of period $ 4,760,000 $ 6,996,000

Source